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Objectives: to evaluate the long-term outcome after recanalisation of chronic iliac artery occlusions by combined catheter
therapy without stent placement.
Design: retrospective study.
Material and methods: between 1979 and 1995 75 consecutive patients were treated (53 men, 22 women; mean age
63.1–13.7 years; mean length of the occluded segment 6.9–3.5 cm). The indication for treatment was incapacitating
claudication (n=55) or chronic critical ischaemia (n=20). At follow-up clinical data, pulse volume and pressure
measurements were recorded and duplex-sonography and/or angiography performed, if clinically indicated.
Results: mean follow-up was 7.2–4.1 years. The primary clinical success rate was 64% at 12 months, 57% at 4 years
and remained stable for up to ten years. The secondary clinical success rate after 12 months was 83% and remained
stable at 81% for up to 10 years. Peripheral embolisation as complication of the intervention occurred in 18 patients
(24%) and was treated by percutaneous thromboembolectomy in 15 patients during the same procedure. In the remaining
three patients no intervention was necessary. One patient had to undergo surgery for a groin haematoma.
Conclusions: recanalisation of segmental chronic iliac artery occlusions by catheter therapy without stent placement has
favourable long-term results comparable to primary stent placement. Randomised controlled studies are required to
determine the appropriate role of catheter therapy alone and primary or selective stenting for iliac artery occlusions.
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Introduction comparing conventional surgery with endovascular
techniques, nor studies comparing different en-
Chronic iliac artery occlusions may be managed con- dovascular techniques. Despite the lack of sound sci-
entific proof, primary stenting has now become aservatively, by conventional surgery, or by en-
dovascular techniques. Percutaneous transluminal widespread routine procedure.
The purpose of this study was to analyse retro-angioplasty (PTA) of a chronic iliac artery occlusion
was first described by Tegtmeyer in 1969.1 In the spectively the long-term outcome of our patients with-
out stenting and to compare it with the data availablefollowing period many authors described the pro-
cedure in small groups of patients.2–6 Subsequently, in the literature for patients treated with stents.
the method was criticised because of a low success
rate associated with a high complication rate7 and also
because of a high complication rate when combined
Patients and Methodswith streptokinase infusions.8 It was at that time looked
upon as an alternative to surgery in the high-risk Between October 1979 and June 1995 a total of 81patient only,9,10 until the method finally proved its patients underwent endovascular treatment for a uni-usefulness in large groups of patients.11,12 Recently, lateral chronic iliac artery occlusion. In 6 of the 81primary stent placement for chronic iliac artery oc- patients primary stenting of the successfully reopenedclusions has been proposed as the preferred option.13–22 iliac segment was performed (the reason for primaryUnfortunately, there are neither randomised studies stenting was a change of clinical practice and this
procedure was not performed before 1993). For the
* Please address all correspondence to: A. J. Leu, Department of purpose of this study these patients were excluded,Internal Medicine, Division of Angiology, University Hospital,
Ra¨mistr. 100, CH-8091 Zu¨rich, Switzerland. leaving a total of 75 patients treated without stents.
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Table 1. Patient characteristics (percentages are given in par- a removable haemostatic valve (Cordis, Waterloo, Bel-
entheses). n=75. y=years. cm=centimetres.
gium) was inserted into the femoral artery using the
Mean age 63.1–13.7 y Seldinger technique and 5000 I.U. of herparin were
Male:female 53:22 (71%:29%) given intra-arterially. The French size of the sheath
Risk factors:
ranged from 5 to 9 and was selected depending on thesmoking 57 (76%)
hyperlipidemia 25 (33%) catheters used. Under fluoroscopic control, a steerable
hypertension 24 (32%) guidewire was passed through the occlusion.diabetes 14 (19%)
When a soft occlusion suggested thrombotic ma-obesity (body mass index >25) 21 (28%)
Claudication 55 (73%) terial, local thrombolysis (LTL) was performed by
Chronic critical ischaemia 20 (27%) infiltrating the occlusion with urokinase. For this pur-
pose a microporous balloon catheter (Schneider Eur-
ope, Bu¨lach, Switzerland) was used. The microporous
balloon was positioned in the occlusion and urokinase
Before treatment all patients had a full clinical work- was injected by hand into the thrombus.25 Dosages of
up including systolic ankle blood pressure meas- urokinase ranged between 100 000 and 400 000 I.U.
urements by Doppler ultrasound and pulse volume according to the length of the occlusion (mean
recordings. The patient characteristics are listed in 186 000–65 000 I.U.).
Table 1. The indication for treatment was in- Whenever possible percutaneous throm-
capacitating claudication in 55 patients (73%) (grade I boembolectomy (PTEE) was performed by means of
according to the criteria used by Rutherford et al.23), an end-hole aspiration catheter (Schneider Europe,
and chronic critical ischaemia in 20 patients (27%) Bu¨lach, Switzerland) to remove thrombotic material
(grade II and III). (French size 6–8). The aspiration catheter was ad-
Arteriography revealed occlusion of the common vanced into the proximal part of the occlusion. After
iliac artery in 30 patients (40%), whereas the external removal of the guidewire, negative pressure was es-
iliac artery was occluded in 38 patients (51%). Oc- tablished by means of a 50-ml syringe and the throm-
clusion involved both vessel segments in 4 cases (5%) botic material was sucked into the syringe or trappedand in another 3 patients (4%) the external iliac artery
at the tip of the catheter, which was then carefullywas occluded extending into the common femoral
retracted to remove the clot. Thrombotic materialartery. Mean length of the occlusion was 6.9–3.5 cm.
trapped at the haemostatic valve of the introducingThe left iliac arteries were more frequently involved
sheath was removed by taking off the valve after thecompared to the right (50 versus 25 cases). In 6 patients
sheath was occluded with a clamp.25,26 The procedure(8%) the occluded iliac segment had been treated
was repeated as long as thrombotic material could bepreviously by PTA, and in another 2 patients (3%)
aspirated or angiography suggested residual throm-endarterectomy of the occluded iliac segment had been
botic material. Any residual stenosis was balloon di-performed.
lated. Conventional balloon angioplasty (PTA) wasAdditional chronic arterial occlusive disease in the
primarily used in chronic occlusions. The mean dia-same limb (defined as >50% stenosis or occlusion
meter of the balloon catheter was 7.2–0.8 mm.of the femoropopliteal artery and/or the profunda
The technical result of the procedure was assessedfemoris and/or occlusion of at least two calf arteries)
by arteriography immediately after intervention. Thewas present in 34 patients (45%). A stenosis >50% or
procedure was considered technically successful if theocclusion involved the common femoral artery in 3
occluded vessel segment was reopened. The an-(4%), the superficial femoral artery in 29 (39%), the
giographic result was graded into the following cat-profunda femoris in 1 (1%), and the popliteal artery
egories: no residual stenosis, <50% residual stenosis,in 4 patients (5%). Six patients (8%) had occlusion of
and >50% residual stenosis.two and 4 patients (5%) of three calf arteries.
All patients were re-examined the day after theThe mean ankle systolic pressure was
intervention, 3, 6 and 12 months later, and then on82.4–25.0 mmHg with a mean ankle–brachial index
a yearly basis. Follow-up comprised the following:of 0.58–0.17. All patients had a pathological pulse
history and clinical examination, systolic ankle pres-volume recording at the thigh (according to the criteria
sure measurements, pulse volume recordings, duplexof Strandness).24
sonography and/or angiography, if symptomsVascular access was achieved by an ipsilateral 46
worsened or recurred.(61%), contralateral 7 (9%), or bilateral 22 (30%) trans-
Success was defined according to the criteria offemoral approach.
After local anaesthesia an introducing sheath with Rutherford et al.,23 i.e. increase of the ankle–brachial
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index of at least 0.10 and upward shift by at least one After the successful procedure 30 of the 67 patients
received heparin for one to three days (100 000–200 000clinical category in those patients without actual tissue
loss and two clinical categories in those with actual I.U. per day). (In our early experience heparin was
always given, in recent years this therapy was dis-tissue loss. No treadmill tests were performed.
continued.) Secondary drug prophylaxis after catheter
therapy consisted of aspirin in 55 patients and cou-
madine in 19 patients (these patients had an indication
Statistics for oral anticoagulation independent of the inter-
vention). Seven patients received both aspirin and
Cumulative success rates were calculated according coumadine. After the intervention the systolic ankle
to the life-table method. The Wilcoxon test for paired pressure in the 75 patients increased from
samples was used as appropriate. A p-value <0.05 was 82.4–25.0 mmHg to 103.7–37.1 mmHg (p<0.01) and
considered significant. the ankle–brachial-index from 0.58–0.17 to 0.77–0.20
(p<0.01).
From the 8 patients in whom endovascular therapy
failed 2 patients underwent endarterectomy of the iliacResults
artery, in one patient a femorofemoral crossover bypass
was performed and 2 patients were treated con-Technical result
servatively. The remaining 3 patients were lost to
follow-up. No complication was encountered duringPrimary failure occurred in 8 of the 75 patients (11%)
the initial failure.due to failure to cross the lesion with a guidewire.
Technical success was therefore achieved in 67 patients
(89%). Postinterventional arteriography showed that
46 of the 67 successfully treated patients had an ex-
cellent technical result without residual stenosis (of
these patients 6% later had reocclusion and 9% had Follow-up
PTA for restenosis). In 14 patients there was a residual
stenosis of less than 50% (21% later had reocclusion The mean follow-up time in this study reached 7.2–4.6
years. Eleven patients were lost to follow-up (15%).and 43% had PTA for restenosis), whereas in 7 patients
postinterventional arteriography still showed a greater Ten of the 11 patients were already lost to follow-up
at the first visit within 3 months of intervention.than 50% stenosis (29% later had reocclusion and 29%
PTA for restenosis). Table 2 summarises the results of the life-table ana-
lysis for the follow-up period. In the 75 patients in-In 29 of the 67 successfully treated patients re-
canalisation of the occluded segment was achieved by cluded in this study 27 interval failures occurred
during the entire follow-up period. Most of the intervalPTA only. In the other patients combined catheter
therapy was performed as follows: twenty-five patients clinical failures were observed during the first year
after treatment (24/27), whereas only three clinicalunderwent PTA combined with local thrombolysis
(LTL), five patients had PTA combined with per- failures were observed during the first year after ther-
apy. The corresponding primary clinical success ratecutaneous thromboembolectomy (PTEE), and in eight
patients a combination of LTL, PTEE and PTA was was 64% at one year which dropped to 57% at 4 years
and remained stable at this level up to 10 years (Fig.used.
Table 2. Life table.
Interval No. at risk No. failed Withdrawn Interval Cumulative
(months) at beginning during during failure success rate and
of interval interval interval rate standard error
0–3 75 16 10 0.229 77.1–4.3
3–6 49 4 1 0.082 70.7–5.5
6–12 44 4 2 0.093 64.1–5.8
12–24 38 1 8 0.029 62.2–6.2
24–36 29 1 5 0.038 59.8–7.0
36–48 23 1 5 0.049 56.9–7.8
48–60 17 0 5 0 56.9–9.1
60–72 12 0 1 0 56.9–10.8
72–120 11 0 6 0 56.9–11.3
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Table 3. Reinterventions necessary to maintain clinical success were performed at the following time-points: 4 re-
during the observation period. n=number of patients. *1 patient interventions between 0–3 months, 6 between 3–6had Re-PTA for the treated iliac segment and 2 additional PTA
for other ipsilateral segments. months, 4 between 6–12 months, 1 between 2–3 years,
and 1 between 3–4 years.
Treated iliac segment 13 (n=13)
Reocclusion with clinical failure not amenable toStenosis (Catheter therapy) 11
Occlusion (Catheter therapy 2 catheter therapy occurred in 5 patients resulting in a
secondary clinical success rate as given in Fig. 1. ThreeOther ipsilateral segment 3 (n=2)
Stenosis (Catheter therapy) 2 failures occurred in the first 24 hours, one in the first
Occlusion (Femoro-popliteal Bypass) 1 three months and one between 6 and 12 months after
Total 16 (n=14*) the intervention. Three of these patients had to undergo
endarterectomy, whereas 2 were treated conserv-
atively.
During the follow-up no major amputations oc-1). As a consequence of the 27 interval failures 16
curred. In one patient with rest pain 3 necrotic toessuccessful reinterventions in 14 patients were per-
were amputated a few days after successful inter-formed in order to maintain the initial success (Table
vention with subsequent primary wound healing.3). In 13 patients reinterventions were necessary for the
The ankle–brachial-index was as following (timetreated iliac segment (11 reinterventions for restenosis
after intervention is given in parentheses): 0.89–0.19and 2 for reocclusion) whereas in 2 patients 3 in-
(3 months), 0.90–0.20 (6 months), 0.92–0.19 (1 year),terventions were performed for disease in other seg-
0.93–0.19 (2 years), 0.97–0.2 (3 years), 0.99–0.19ments of the same limb: in one patient (who also had
(4 years), 0.98–0.22 (5 years), 0.96–0.24 (6 years),restenosis of the iliac segment) PTA of a stenotic
1.08–0.05 (10 years). The p-value between ankle–superficial femoral artery was performed and another
brachial index before and after therapy was statisticallypatient underwent PTA of the common femoral artery
and a femoropopliteal bypass. These reinterventions significant for all values (p<0.01).
Fig. 1. Primary and secondary cumulative success curve by life-table method (number of patients entering the respective time
period are given in parentheses).
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Fig. 2. Survival curve by life-table method (number of patients entering the respective time period are given in parentheses). The
standard deviation did not exceed 10% during the whole observation time.
Table 4. Complications of the intervention and their managementSurvival rate
(percentages are given in parentheses). PTEE=percutaneous
thromboembolectomy.
The cumulative survival rate is shown in Fig. 2.
Distal embolisation 18 (24%)Twenty-seven of the 75 patients died during the ob-
(PTEE 15; Conservative 3)servation period, resulting in a cumulative survival
Haematoma 3 (4%)rate of 63% after 5 years decreasing to 39% after 10 (Surgery 1; Conservative 2)
years. Twenty-one patients died with a patent and 6
False aneurysm 1 (1%)with an occluded iliac segment (3 initial failures, 3 (Conservative 1)
failures during follow-up). The cause of death was:
myocardial infarction in 6 cases, heart failure in 5,
stroke in 2, giant cell arteritis in 1, lung cancer in 5,
cancer of the pancreas in 1, and bleeding due to oral
anticoagulation in 1. In 6 patients the reason for death
could not be determined.
procedure via an ipsilateral antegrade puncture of the
common femoral artery. In 3 patients distal-calf emboli
were not removed without any clinical conseqences.
In the time period between 1979 and 1990, nine em-Complications (Table 4)
bolisations in 36 interventions (25%) occurred, whereas
between 1990 and 1995 nine embolisations in 39 in-During recanalisation of the iliac artery distal em-
bolisation occurred in 18 patients (24%). The exact terventions were observed (23%). Three patients (4%)
developed a groin haematoma after the intervention.time-point of the embolisations during the intervention
could not be determined, as it was in general detected Two patients were treated conservatively, and 1 patient
required surgical evacuation of the haematoma. Oneby routine arteriography of the lower extremities at
the end of the examination. In 15 patients emboli patient (1%) had a false aneurysm which was suc-
cessfully treated by ultrasound-guided compression.were successfully removed by PTEE during the same
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Discussion a meta-analysis of the results of percutaneous trans-
luminal angioplasty and stent placement for aortoiliac
This retrospective study is a single institution ex- occlusive disease has been published.28 Surprisingly,
stent placement for iliac occlusions did not yield betterperience of treating chronic iliac artery occlusions
without stenting with a mean follow-up of 7.2 years. immediate treatment results than PTA alone. However,
a slightly better 4-year primary patency rate for stentSuccess was defined according to the criteria of Ruth-
erford et al.,23 i.e. increase of the ankle–arm index of placement in iliac occlusions (61% for claudicants and
53% for critical ischemia) versus PTA alone (54% andat least 0.10 and upward shift by at least one clinical
category in those patients without actual tissue loss 44%, respectively) was found. Our primary success
rate of 57% at 4 years is similar to the results foundand two clinical categories in those with actual tissue
loss. The initial technical success rate reached 89% in in the meta-analysis for primary stent placement.
Most recently the first randomised controlled studythis series. The primary clinical success rate at 4 years
was 57% and remained stable for up to 10 years. A comparing primary stent placement against primary
angioplasty followed by selective stent placement intotal of 16 reinterventions in 13 patients, including 3
interventions in 2 patients in the femoropopliteal ar- patients with iliac artery occlusive disease (stenoses
and occlusions) has been reported.29 In this studytery, were necessary to maintain the clinical success.
This resulted in a secondary clinical success rate of stenting was only performed following the de-
monstration of a residual mean pressure gradient81% at 4 to 10 years.
The long-term result of treating chronic iliac artery greater than 10 mmHg across the treated site. In-
terestingly, no significant differences in technicalocclusions with conventional balloon dilatation has
been rarely reported in larger series in the literature results or clinical outcomes of the two treatment strat-
egies were found. As the rate of occlusions in thisand often the results have been mixed together with
the treatment of iliac artery stenosis or even femo- study was only 11% an most of them were stented it
is still open to discussion whether this strategy wouldropopliteal lesions. There are only two larger retro-
spective studies dedicated to iliac artery occlusions yield similar results for iliac occlusions. Our study
showed a rather high complication rate mostly due towhich, however, do not report the results on an in-
tention-to-treat basis.11,12 Colapinto found a cumulative distal embolisation in 18 patients (24%). However,
emboli were removed successfully during the samepatency rate of 78% over a 4-year period in 64 patients,
but the initial failure rate of 14% was not included. catheter intervention by aspiration embolectomy in 15
patients or were treated conservatively in 3 patientsGupta reported a patency rate of 63% at 6 years. Again
the initial failure rate of 21% was not considered in with no clinical consequences. Our data contrast with
the data of Vorwerk who found distal embolisation inthe analysis.
In the large series of 667 PTAs of the iliac arteries only 4.8% after primary stent placement.27 In the meta-
analysis mentioned above major complication ratespublished by Johnston 82 iliac artery occlusions were
included. In this subgroup he reported on a patency were similar for primary stent placement and PTA
alone (4–5%), although the rate of distal embolisationrate of 48% at 3 years based on an intention-to-treat
analysis.27 The results of our study are consistent with was not particularly analysed.28 We cannot ignore the
suggestion that the high embolisation rate found in ourthe available literature data. Since we report on clinical
success rates rather than patency rates, clinical failures study might be associated with the technical aspects of
local thrombolysis or thrombus aspiration. Our currentwere not exclusively due to re-occlusion of the iliac
artery but also included disease progression in the personal experience with primary stent placement for
chronic iliac occlusions over 6 years indicates a sub-femoropopliteal artery in 2 patients. Thus one may
speculate that the patency rate in our study might be stantially lower rate of distal embolisation using this
procedure. We have no evidence that distal em-even slightly higher than the clinical success rate.
Primary stenting of iliac artery occlusions has been bolisation was associated with our learning curve,
since the rate of embolisation was similar between theincreasingly used in the last years.13–22 In the largest
series Vorwerk reported on his experience in 103 years 1979–1989 and 1990–1995.
The mortality rate in our study was 37% at fivepatients.20 He found a primary patency rate of 78%
and a secondary patency rate of 88% after 4 years. years. After ten years slightly more than one third of
our patients were still alive. This is consistent withAgain the initial failure rate of 19% was not included.
In his publication Vorwerk admits that the patency epidemiological studies showing a considerably re-
duced life expectancy in patients with advancedrate achieved was similar to that for conventional PTA
as reported in the studies mentioned above. Recently atherosclerosis.30
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